International Antiaging Systems
 Welcome to IAS
Contact Us
 Product
 Further Reading
 Miscellaneous
Online Store A-Z Product List eNews Special Offers
 Aricept / Donepezil ® - Manufacturer's Insert

Composition:

Aricept is available for oral administration in film-coated tablets containing 5 or 10 mg of donepezil hydrochloride. Inactive ingredients are lactose monohydrate, corn starch, microcrystalline cellulose, hydroxypropyl cellulose, and magnesium stearate. The film coating contains talc, polyethylene glycol, hypromellose and titanium dioxide. Additionally, the 10 mg tablet contains yellow iron oxide (synthetic) as a coloring agent.

Information for the User:

ARICEPT ® (donepezil HCl) is indicated for the treatment of symptoms of mild to moderate Alzheimer's disease. The 10 mg tablets are yellow. The strength, in mg (10), is debossed on one side and ARICEPT is debossed on the other side.

Caution:

Because strategies for the management of overdose are continually evolving, it is advisable to contact a Poison Control Center to determine the latest recommendations for the management of an overdose of any drug. 

As in any case of overdose, general supportive measures should be utilized. Overdosage with cholinesterase inhibitors can result in cholinergic crisis characterized by severe nausea, vomiting, salivation, sweating, bradycardia, hypotension, respiratory depression, collapse and convulsions. Increasing muscle weakness is a possibility and may result in death if respiratory muscles are involved. Tertiary anticholinergics such as atropine may be used as an antidote for ARICEPT ® overdosage. Intravenous atropine sulfate titrated to effect is recommended: an initial dose of 1.0 to 2.0 mg IV with subsequent doses based upon clinical response. Atypical responses in blood pressure and heart rate have been reported with other cholinomimetics when co-administered with quaternary anticholinergics such as glycopyrrolate. It is not known whether ARICEPT ® and/or its metabolites can be removed by dialysis (hemodialysis, peritoneal dialysis, or hemofiltration). Dose-related signs of toxicity in animals included reduced spontaneous movement, prone position, staggering gait, lacrimation, clonic convulsions, depressed respiration, salivation, miosis, tremors, fasciculation and lower body surface temperature. 

Side Effects:

ARICEPT ® (donepezil HCl) is well tolerated but may not be for everyone. Some people may experience nausea, diarrhea, insomnia, vomiting, muscle cramps, fatigue or loss of appetite. In studies, these side effects were usually mild and temporary. Some people taking ARICEPT ® (donepezil HCl) may experience fainting. People at risk for ulcers should tell their doctors because their condition may get worse.

Directions:

The dosages of ARICEPT ® shown to be effective in controlled clinical trials are 5 mg and 10 mg administered once per day.

The higher dose of 10 mg did not provide a statistically significantly greater clinical benefit than 5 mg. There is a suggestion, however, based upon order of group mean scores and dose trend analyses of data from these clinical trials, that a daily dose of 10 mg of ARICEPT ® might provide additional benefit for some patients. Accordingly, whether or not to employ a dose of 10 mg is a matter of prescriber and patient preference.

Evidence from the controlled trials indicates that the 10 mg dose, with a one week titration, is likely to be associated with a higher incidence of cholinergic adverse events than the 5 mg dose. In open label trials using a 6 week titration, the frequency of these same adverse events was similar between the 5 mg and 10 mg dose groups. Therefore, because steady state is not achieved for 15 days and because the incidence of untoward effects may be influenced by the rate of dose escalation, treatment with a dose of 10 mg should not be contemplated until patients have been on a daily dose of 5 mg for 4 to 6 weeks.

ARICEPT ® should be taken in the evening, just prior to retiring. ARICEPT ® can be taken with or without food.

Please follow your doctor's instructions.

Prescription Conditions:

This product has been prescribed for you in order to remedy a particular medical problem.
Do not use it to treat other ailments.
Do not use it again without first consulting your doctor.
Do not use it to treat another person.
Consult your doctor.

Many people take more than one medicine. Always check with the doctor before taking any other medicines with Aricept. These include:

Prescriptions
Home remedies
Vitamins
Herbal remedies
Aspirin
Dietary supplements
Cold and allergy medicines
Other over the counter treatments

The above information is the translation of the manufacturer's insert. It is provided under the supplying company's terms and conditions and should not replace the advice of your personal physician.

TOP

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 2.5 License.

Aricept
No longer available.

Customers who have bought Aricept have also been interested in the following items:

Memantine
Reminyl
Deprenyl